These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32878018)

  • 1. Anti-Tubercular Properties of 4-Amino-5-(4-Fluoro-3- Phenoxyphenyl)-4
    Venugopala KN; Kandeel M; Pillay M; Deb PK; Abdallah HH; Mahomoodally MF; Chopra D
    Antibiotics (Basel); 2020 Aug; 9(9):. PubMed ID: 32878018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Drug Design of Thiolactomycin Derivatives Against Mtb-KasA Enzyme to Inhibit Multidrug Resistance of Mycobacterium tuberculosis.
    Durairaj DR; Shanmughavel P
    Interdiscip Sci; 2019 Jun; 11(2):215-225. PubMed ID: 28856604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
    Slayden RA; Lee RE; Barry CE
    Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow onset inhibition of bacterial beta-ketoacyl-acyl carrier protein synthases by thiolactomycin.
    Machutta CA; Bommineni GR; Luckner SR; Kapilashrami K; Ruzsicska B; Simmerling C; Kisker C; Tonge PJ
    J Biol Chem; 2010 Feb; 285(9):6161-9. PubMed ID: 20018879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology modeling and docking studies of FabH (β-ketoacyl-ACP synthase III) enzyme involved in type II fatty acid biosynthesis of Chlorella variabilis: a potential algal feedstock for biofuel production.
    Misra N; Patra MC; Panda PK; Sukla LB; Mishra BK
    J Biomol Struct Dyn; 2013 Mar; 31(3):241-57. PubMed ID: 22830394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual screening and identification of promising therapeutic compounds against drug-resistant
    Andrianov AM; Furs KV; Gonchar AV; Skrahina AM; Wang Y; Lyu LD; Tuzikov AV
    J Biomol Struct Dyn; 2023 Dec; ():1-13. PubMed ID: 38088766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insight into conformational dynamics of non-active site mutations in KasA: A Mycobacterium tuberculosis target protein.
    Jayaraman M; Rajendra SK; Ramadas K
    Gene; 2019 Dec; 720():144082. PubMed ID: 31476406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
    Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
    Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
    Venugopala KN; Chandrashekharappa S; Pillay M; Abdallah HH; Mahomoodally FM; Bhandary S; Chopra D; Attimarad M; Aldhubiab BE; Nair AB; Sreeharsha N; Morsy MA; Pottathil S; Venugopala R; Odhav B; Mlisana K
    PLoS One; 2019; 14(6):e0217270. PubMed ID: 31163040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Insight into how β-Ketoacyl ACP Synthase I (KasA) Recognizes the Fatty Acid Chain Length of its Substrate.
    Lee W
    Chempluschem; 2024 Jul; 89(7):e202300568. PubMed ID: 37983623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing.
    Mtewa AG; Bvunzawabaya JT; Ngwira KJ; Lampiao F; Maghembe R; Okella H; Weisheit A; Tolo CU; Ogwang PE; Sesaazi DC
    Sci Afr; 2021 Jul; 12():e00824. PubMed ID: 37215382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of 1,2,4-Triazole-5-Thione Derivatives as Potential Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) in Tuberculosis.
    Vora D; Upadhyay N; Tilekar K; Jain V; Ramaa CS
    Iran J Pharm Res; 2019; 18(4):1742-1758. PubMed ID: 32184843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis.
    Kremer L; Douglas JD; Baulard AR; Morehouse C; Guy MR; Alland D; Dover LG; Lakey JH; Jacobs WR; Brennan PJ; Minnikin DE; Besra GS
    J Biol Chem; 2000 Jun; 275(22):16857-64. PubMed ID: 10747933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis.
    Kremer L; Dover LG; Carrère S; Nampoothiri KM; Lesjean S; Brown AK; Brennan PJ; Minnikin DE; Locht C; Besra GS
    Biochem J; 2002 Jun; 364(Pt 2):423-30. PubMed ID: 12023885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations.
    Shamim A; Abbasi SW; Azam SS
    J Mol Graph Model; 2015 Jul; 60():180-96. PubMed ID: 26059477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies.
    Venugopala KN; Chandrashekharappa S; Deb PK; Al-Shar'i NA; Pillay M; Tiwari P; Chopra D; Borah P; Tamhaev R; Mourey L; Lherbet C; Aldhubiab BE; Tratrat C; Attimarad M; Nair AB; Sreeharsha N; Mailavaram RP; Venugopala R; Mohanlall V; Morsy MA
    Int J Biol Macromol; 2024 Jun; 274(Pt 2):133285. PubMed ID: 38925196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid synthesis. Role of active site histidines and lysine in Cys-His-His-type beta-ketoacyl-acyl carrier protein synthases.
    von Wettstein-Knowles P; Olsen JG; McGuire KA; Henriksen A
    FEBS J; 2006 Feb; 273(4):695-710. PubMed ID: 16441657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
    Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
    Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-
    Venugopala KN; Uppar V; Chandrashekharappa S; Abdallah HH; Pillay M; Deb PK; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Tratrat C; Yousef Jaber A; Venugopala R; Mailavaram RP; Al-Jaidi BA; Kandeel M; Haroun M; Padmashali B
    Antibiotics (Basel); 2020 May; 9(5):. PubMed ID: 32392709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.